Article

Mississippi to reimburse for TTT of wet AMD

Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).

Related Videos
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Related Content
Microdrops show promise for safer retinopathy of prematurity screening in preterm infants
January 3rd 2025

Microdrops show promise for safer retinopathy of prematurity screening in preterm infants

Commercial real estate and your practice, part two with Colin Carr
May 21st 2022

Commercial real estate and your practice, part two with Colin Carr

Strabismus in animation: study highlights harmful stereotypes in children's films
November 28th 2024

Strabismus in animation: study highlights harmful stereotypes in children's films

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
May 12th 2022

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

NIH highlights 5 key elements of cortical visual impairment (CVI)
November 23rd 2024

NIH highlights 5 key elements of cortical visual impairment (CVI)

Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
November 18th 2024

Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease

© 2025 MJH Life Sciences

All rights reserved.